Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,040 public trials 1,028 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Completed

F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence

NCT04102553

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Centre Jean Perrin Clermont-Ferrand Clermont-Ferrand, France
  • Centre Léon Bérard LUMEN Lyon, France
  • Hôpitaux de Brabois (Vandoeuvre-les-Nancy) Nancy, France
  • Hôpital Européen Georges-Pompidou Paris, France
View Trial Details
Completed

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients

NCT03017313

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Hospital A Coruña A Coruña, Spain
  • Hospital del Sureste Arganda, Spain
  • Hospital San Agustín Avilés, Spain
  • Hospital de Txagorritxu Barakaldo, Spain
View all 27 locations
View Trial Details
Completed

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

NCT00003653

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
View all 29 locations
View Trial Details
Completed

Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer

NCT00667862

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +16 more
Locations
  • University of Maryland Baltimore, Maryland, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Washington University St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

NCT03361969

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • Andros Men's Health Institutes Arnhem, Gelderland, Netherlands
  • Noord West Ziekenhuis Alkmaar, Netherlands
  • St Antonius Ziekenhuis Nieuwegein, Netherlands
  • CWZ Nijmegen, Netherlands
View Trial Details

Related conditions